Clinical characteristics and selection of treatment modality for patients with vitreomacular traction: real-world implementation of NICE guidance (TA297)
Edward William James Pritchard,1 Shams-Ulislam Ilyas,1 Soha Khaled Amar,2 Yit Chuin Yang,3 Nirodhini Narendran1 1Ophthalmology Department, Wolverhampton Eye Infirmary, New Cross Hospital, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, 2College of Medical and Dental Sciences, University of...
Guardado en:
Autores principales: | Pritchard EWJ, Ilyas SU, Amar SK, Yang YC, Narendran N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c811482e8d074e6c96a50e9726014739 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
por: Hubschman S, et al.
Publicado: (2020) -
Prevalence of vitreomacular adhesion: an optical coherence tomography analysis in the retina clinic setting
por: Reichel E, et al.
Publicado: (2016) -
Ocriplasmin: who is the best candidate?
por: Prospero Ponce CM, et al.
Publicado: (2016) -
Clinical Features of Vitreomacular Traction Syndrome with Peripheral Vitreoretinal Adhesion
por: Fukumoto M, et al.
Publicado: (2020) -
Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)
por: Drenser KA, et al.
Publicado: (2021)